1. Summary Information
|
Country |
India |
||
|
Company Name |
AKUMS DRUGS AND
PHARMACEUTICALS LIMITED |
Principal Name 1 |
Mr. Sanjeev Jain |
|
Status |
Good |
Principal Name 2 |
Mr. Sandeep Jain |
|
Registration # |
55-125888 |
||
|
Street Address |
304, Mohan Place, LSC, Saraswati Vihar, New Delhi-110 034, India |
||
|
Established Date |
19.04.2004 |
SIC Code |
-- |
|
Telephone# |
91-11-47511000 (30 lines) |
Business Style 1 |
Manufacturing |
|
Fax # |
91-11-27023256 |
Business Style 2 |
-- |
|
Homepage |
Product Name 1 |
Formulations |
|
|
# of employees |
5500
(Approximately) |
Product Name 2 |
-- |
|
Paid up capital |
Rs. 11,750,000/- |
Product Name 3 |
-- |
|
Shareholders |
Directors or
relatives of Directors 100.00% |
Banking |
Standard Chartered Bank |
|
Public Limited Corp. |
NO |
Business Period |
10 Years |
|
IPO |
NO |
International Ins. |
- |
|
Public |
NO |
Rating |
A (60) |
|
Related
Company |
|||
|
Relation
|
Country
|
Company
Name |
CEO |
|
Associates Concern: |
|
Upadhrish Reserchem LLP |
-- |
|
Note |
- |
||
2. Summary
Financial Statement
|
Balance Sheet as of |
31.03.2013 |
(Unit: Indian Rs.) |
|
|
Assets |
Liabilities |
||
|
Current Assets |
2,890,231,000 |
Current Liabilities |
1,352,805,000 |
|
Inventories |
1,110,488,000 |
Long-term Liabilities |
504,692,000 |
|
Fixed Assets |
2,607,009,000 |
Other Liabilities |
457,644,000 |
|
Deferred Assets |
0,000 |
Total Liabilities |
2,315,141,000 |
|
Invest& other Assets |
19,047,000 |
Retained Earnings |
4,299,884,000 |
|
|
|
Net Worth |
4,311,634,000 |
|
Total Assets |
6,626,775,000 |
Total Liab. & Equity |
6,626,775,000 |
|
Total Assets (Previous Year) |
6,119,326,000 |
|
|
|
P/L Statement as of |
31.03.2013 |
(Unit: Indian Rs.) |
|
|
Sales |
7,939,537,000 |
Net Profit |
1,080,325,000 |
|
Sales(Previous yr) |
6,496,314,000 |
Net Profit(Prev.yr) |
687,386,000 |
MIRA INFORM REPORT
|
Report Date : |
26.03.2014 |
IDENTIFICATION DETAILS
|
Name : |
AKUMS DRUGS AND PHARMACEUTICALS LIMITED |
|
|
|
|
Registered
Office : |
304, Mohan Place, LSC, Saraswati Vihar, New Delhi-110 034 |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2013 |
|
|
|
|
Date of
Incorporation : |
19.04.2004 |
|
|
|
|
Com. Reg. No.: |
55-125888 |
|
|
|
|
Capital Investment
/ Paid-up Capital : |
Rs. 11.750 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24239DL2004PLC125888 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
DELA13882B |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAECA7090B |
|
|
|
|
Legal Form : |
A Closely held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
Subject undertakes contract manufacturing of
formulations. |
|
|
|
|
No. of Employees
: |
5000 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
A (60) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
Maximum Credit Limit : |
USD 17000000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well-established and reputed company having fine track
record. The rating reflects company’s healthy financial risk profile, marked
by healthy growth in revenues and profitability. The rating also reflects
diversified customer profile and stable credit profile. Trade relations are reported as fair. Business is active. Payment are
reported to be regular and as per commitments. The company can be considered good for normal business dealings at
usual trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 1, 2013
|
Country Name |
Previous Rating (30.09.2013) |
Current Rating (01.12.2013) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INDIAN ECONOMIC OVERVIEW
India’s current account deficit for the fiscal third quarter ended September
2013 narrowed to $4.2 billion or 0.9 % of the gross domestic product from $31.9
billion or 6.5 % of GDP a year earlier, thanks to a pick-up in exports and
moderation in gold imports. Manufacturing activity and new orders in India
showed their strongest growth in a year in February. The news comes as a relief
after data showed Asia’s third largest economy grew by a slower-than-expected
4.7 % annually in the three months through December. The HSBC Manufacturing
Purchasing Managers’ Index which gauges the business activity of India’s
factories but not its’ utilities, rose to 52.5 in February, its highest in a
year from 51.4 in January. Overall new orders for factory goods which rose to a
one-year high of 54.9 contributed to the surge. China has emerged as India’s
biggest trading partner in the current financial year replacing the United Arab
Emirates and pushing it to the third spot. India-China trade has reached $49.5
billion with a 8.7 % share in India’s total trade. The US comes second at $46
billion with 8.1 % share during the first nine months of the current financial
year.
The Reserve Bank of India has granted an additional nine months to the
public to exchange currency notes printed before 2005 including Rs 500 and Rs
1,000 denominations, pushing the deadline to January 1, 2015. A day before
dates for the Lok Sabha polls were announced, the government decided to hike
interest rates on fixed deposit schemes offered by post offices up to 0.2 per
cent. The new rates will be effective April, 1. The Supreme Court will resume
hearing on March, 11 Nokia’s appeal against a ruling over transferring
ownership of its local mobile phones plant which is the subject of a tax
dispute to Microsoft Corp.
In the last days of the current Government, another scam has surfaced.
The defence ministry has ordered a probe into Hindustan Aeronautics Limited’s
contracts from Britain’s Rolls-Royce Holdings worth at least $ 1.2 billion. The
Central Bureau of Investigation will look into allegations that over $80
million was paid in kickbacks in a deal signed in 2011. India has asked Boeing
Co. to find a solution for problems with state-owned Air India’s 787
Dreamliners. The aircraft has experienced a series of malfunctions since its
debut in 2011.
EXTERNAL AGENCY RATING
|
Rating Agency Name |
ICRA |
|
Rating |
Term Loans: A+ |
|
Rating Explanation |
Adequate degree of safety and low credit risk. |
|
Date |
January 2014 |
|
Rating Agency Name |
ICRA |
|
Rating |
Non fund based facilities: A1+ |
|
Rating Explanation |
Very strong degree of safety and lowest credit risk. |
|
Date |
January 2014 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
INFORMATION PARTED BY
|
Name : |
Mr. Sanjay Agarwal |
|
Designation : |
General Manager Accounts and Finance |
|
Contact No.: |
91-11-47511000 |
|
Date : |
14.03.2014 |
LOCATIONS
|
Registered Office / Corporate Office : |
304, |
|
Tel. No.: |
91-11-47511000 (30 lines) |
|
Fax No.: |
91-11-27023256 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Manufacturing Unit I |
13,19,20,21,22,47,48 Sector-6A, I.I.E., SIDCUL, Ranipur,
Haridwar - 249403, Uttarakhand India |
|
Tel. No.: |
91-1334-239220 – 224, 325982, 84, 85,86 |
|
Fax No.: |
91-1334-239219 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Manufacturing Unit II |
22, Sector-6A, IIE, SIDCUL, Ranipur, Haridwar - 249403 Uttarakhand, India |
|
Tel. No.: |
91-1334-239220 – 224, 325982, 84 ,85, 86 |
|
Fax No.: |
91-1334-239219 |
|
E-Mail : |
|
|
|
|
|
Manufacturing Unit III |
2,3,4,5 Sector-6B, IIE, SIDCUL, Ranipur, Haridwar - 249403
|
|
Tel. No.: |
91-1334- 237100 – 104 |
|
Fax No.: |
91-1334-237105 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Manufacturing Unit IV : |
47, Sector 6B, SIDCUL, Ranipur, Haridwar - 249403 |
|
|
|
|
Manufacturing Unit V : |
48, Sector 6B, SIDCUL, Ranipur, Haridwar - 249403 |
|
|
|
|
Manufacturing Unit VI : |
13, Sector – 6A, SIDCUL, Intergrated Industrial Estate
Ranipur, Haridwar – 249403, |
DIRECTORS
As on 12.08.2013
|
Name : |
Mr. Sanjeev Jain |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Whole-time Director |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
E – 1052, Saraswati Vihar, Dehli – 110 034, |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
11.04.1966 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Qualification : |
MBBS (BIO) MBA |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
01.06.2012 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Voter ID No.: |
DL/03/018/273610 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
00323433 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
PAN No.: |
AAAPJ1891Q |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Mr. Sandeep Jain |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Whole-time Director |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
E – 1052, Saraswati Vihar, Dehli – 110 034, |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
05.08.1967 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Qualification : |
BCom MBA FMSPI AMIMA |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
01.06.2012 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Voter ID No.: |
DL/03/018/273693 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
00323476 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Other Directorship:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Mr. Narendra Dev Sachdeva |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
While-time Director |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
40/22, 3rd Floor, |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
15.10.1950 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Qualification : |
B Pharma (Hons) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
01.04.2012 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
00330005 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
PAN No.: |
AYZPS4234M |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Other
Directorship:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Mr. Nandlal Karla |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Additional Director |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
4 B A 11, Jawahar Nagar, Jaipur – 302 004, |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
05.02.1950 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
01.06.2012 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
05268554 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Name : |
Mr. Debabrata Roy |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Designation : |
Additional director |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Address : |
3081/8th Floor, Beverly Hills Apartment, Geeta Colony, Delhi – 110031,
India |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Date of Birth/Age : |
05.10.1952 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Date of Appointment : |
04.01.2014 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
DIN No.: |
06765777 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
KEY EXECUTIVES
|
Name : |
Mr. Sanjay Agarwal |
|
Designation : |
General Manager Accounts and Finance |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 12.08.2013
|
Names of Shareholders |
No. of Shares |
% age |
|
Sanjeev Jain |
585275 |
49.81 |
|
Lata Jain |
75 |
0.01 |
|
Sanjeev Jain Joint with Arushi Jain |
300 |
0.03 |
|
Lata Jain Joint with Umang Jain |
50 |
0.00 |
|
Sanjeev Jain Joint with Kiran Jain |
1800 |
0.15 |
|
Sandeep Jain |
585350 |
49.82 |
|
Sandeep Jain Joint with Kanishk Jain |
300 |
0.03 |
|
Manan Jain U/G Sandeep Jain |
50 |
0.00 |
|
Sandeep Jain Joint with Kiran Jain |
1800 |
0.15 |
|
Total |
1175000 |
100.00 |
Equity Share Break up (Percentage of Total Equity)
As on 12.08.2013
|
Category |
Percentage |
|
Directors or relatives of Directors |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Subject undertakes contract manufacturing of
formulations. |
||||||
|
|
|
||||||
|
Products : |
|
||||||
|
|
|
||||||
|
Exports : |
|
||||||
|
Products : |
Formulations |
||||||
|
Countries : |
|
||||||
|
|
|
||||||
|
Imports : |
|
||||||
|
Products : |
Raw Material |
||||||
|
Countries : |
|
||||||
|
|
|
||||||
|
Terms : |
|
||||||
|
Selling : |
Credit |
||||||
|
|
|
||||||
|
Purchasing : |
Credit (45 Days) |
PRODUCTION STATUS (As on 31.03.2013)
|
Particulars |
Nos |
Installed Capacity |
Production |
|
Tablets |
Nos. |
2884 Crs |
110,350,625 |
|
Capsules |
Nos. |
555 Crs |
11,000,356 |
|
Dry Syrups |
Nos. |
24 Crs |
338,483 |
|
Liquid Oral |
Nos. |
8.20 Crs |
48 |
|
Liquid Oral |
Kilo Ltrs |
28,080 |
50 |
|
Dry Powder and Liquid Injection |
Nos. |
107.54 Crs |
2,696,112 |
|
Eye/Ear Drops(SVP) |
Nos. |
10.8 Crs |
1,462,628 |
|
Infusion Bottles(LVP) |
Nos. |
2.33 Crs |
193,321 |
|
Pre-filled Syringes |
Nos. |
2.24Crs |
-- |
|
Cosmetic Products |
Kgs |
59,04,000 |
4,643 |
Installed capacity has been certified by the Company, this being a technical matter.
GENERAL INFORMATION
|
Customer: |
|
||||||||||||||||||
|
|
|
||||||||||||||||||
|
No. of Employees : |
5000 (Approximately) |
||||||||||||||||||
|
|
|
||||||||||||||||||
|
Bankers : |
|
||||||||||||||||||
|
|
|
||||||||||||||||||
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Anil Jain D.D and Company Chartered Accountant |
|
Address : |
611, |
|
PAN N Income-tax PAN of auditor or auditor's firm : |
AARFA8414D |
|
|
|
|
Subsidiary Company: |
|
|
|
|
|
Associates Concern: |
|
CAPITAL STRUCTURE
As on 31.03.2013
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
1200000 |
Equity shares |
Rs.10/- each |
Rs. 12.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
1175000 |
Equity shares |
Rs.10/- each |
Rs. 11.750 Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
|
31.03.2013 |
31.03.2012 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
|
11.750 |
11.750 |
|
(b) Reserves & Surplus |
|
4299.884 |
3469.074 |
|
(c) Money
received against share warrants |
|
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money pending
allotment |
|
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
|
4311.634 |
3480.824 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
|
68.600 |
115.943 |
|
(b) Deferred tax liabilities (Net) |
|
205.656 |
213.790 |
|
(c) Other long term
liabilities |
|
18.980 |
15.060 |
|
(d) long-term
provisions |
|
17.721 |
10.394 |
|
Total Non-current
Liabilities (3) |
|
310.957 |
355.187 |
|
|
|
|
|
|
(4)
Current Liabilities |
|
|
|
|
(a) Short
term borrowings |
|
436.092 |
1196.363 |
|
(b) Trade
payables |
|
1079.863 |
787.996 |
|
(c) Other
current liabilities |
|
253.962 |
272.301 |
|
(d) Short-term
provisions |
|
234.267 |
26.655 |
|
Total Current
Liabilities (4) |
|
2004.184 |
2283.315 |
|
|
|
|
|
|
TOTAL |
|
6626.775 |
6119.326 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1)
Non-current assets |
|
|
|
|
(a) Fixed
Assets |
|
|
|
|
(i)
Tangible assets |
|
2578.221 |
2397.658 |
|
(ii) Intangible
Assets |
|
28.788 |
28.020 |
|
(iii)
Capital work-in-progress |
|
6.997 |
112.352 |
|
(iv)
Intangible assets under development |
|
0.000 |
0.000 |
|
(b) Non-current Investments |
|
12.050 |
6.150 |
|
(c) Deferred tax assets (net) |
|
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
|
1218.135 |
522.053 |
|
(e) Other
Non-current assets |
|
0.000 |
0.000 |
|
Total Non-Current
Assets |
|
3844.191 |
3066.233 |
|
|
|
|
|
|
(2)
Current assets |
|
|
|
|
(a) Current
investments |
|
0.000 |
0.000 |
|
(b)
Inventories |
|
1110.488 |
1203.254 |
|
(c) Trade
receivables |
|
1578.479 |
1217.327 |
|
(d) Cash
and cash equivalents |
|
28.863 |
4.641 |
|
(e)
Short-term loans and advances |
|
64.754 |
627.871 |
|
(f) Other
current assets |
|
0.000 |
0.000 |
|
Total
Current Assets |
|
2782.584 |
3053.093 |
|
|
|
|
|
|
TOTAL |
|
6626.775 |
6119.326 |
|
SOURCES OF FUNDS |
|
|
31.03.2011 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
|
|
11.750 |
|
|
2] Share Application Money |
|
|
0.000 |
|
|
3] Reserves & Surplus |
|
|
2781.242 |
|
|
4] (Accumulated Losses) |
|
|
0.000 |
|
|
NETWORTH |
|
|
2792.992 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
|
|
1473.486 |
|
|
2] Unsecured Loans |
|
|
0.000 |
|
|
TOTAL BORROWING |
|
|
1473.486 |
|
|
DEFERRED TAX LIABILITIES |
|
|
171.276 |
|
|
|
|
|
|
|
|
TOTAL |
|
|
4437.754 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
|
|
2180.096 |
|
|
Capital work-in-progress |
|
|
61.909 |
|
|
|
|
|
|
|
|
INVESTMENT |
|
|
6.150 |
|
|
DEFERREX TAX ASSETS |
|
|
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
|
|
1058.686
|
|
|
Sundry Debtors |
|
|
1054.084
|
|
|
Cash & Bank Balances |
|
|
62.142
|
|
|
Other Current Assets |
|
|
0.000
|
|
|
Loans & Advances |
|
|
817.162
|
|
Total
Current Assets |
|
|
2992.074
|
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
|
|
457.152
|
|
|
Other Current Liabilities |
|
|
176.905
|
|
|
Provisions |
|
|
168.418
|
|
Total
Current Liabilities |
|
|
802.475
|
|
|
Net Current Assets |
|
|
2189.599
|
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
|
|
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
|
|
4437.754 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
7939.537 |
6496.314 |
5689.809 |
|
|
|
Other Income |
161.997 |
121.429 |
78.119 |
|
|
|
TOTAL |
8101.534 |
6617.743 |
5767.928 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Consumption materials changes inventories |
-- |
-- |
4015.669 |
|
|
|
Cost raw material consumed |
5408.489 |
4366.087 |
-- |
|
|
|
Changes in inventories of finished goods, work-in-progress and
stock-in-trade |
5408.489 |
68.053 |
-- |
|
|
|
Manufacturing service costs |
-- |
-- |
181.937 |
|
|
|
Employee related expenses |
757.364 |
651.073 |
489.307 |
|
|
|
Administrative selling other expenses |
-- |
-- |
110.915 |
|
|
|
Other expenses |
485.720 |
433.989 |
-- |
|
|
|
Exceptional items |
175.228 |
-- |
-- |
|
|
|
TOTAL |
6779.900 |
5519.202 |
4797.828 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION |
1321.634 |
1098.541 |
970.100 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
113.362 |
122.242 |
91.666 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION |
1208.272 |
976.299 |
878.434 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
127.947 |
109.837 |
89.339 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX |
1080.325 |
866.462 |
789.095 |
|
|
|
|
|
|
|
|
|
Less |
TAX |
249.514 |
179.076 |
173.392 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
|
830.811 |
687.386 |
615.703 |
|
|
|
|
|
|
|
|
|
Add |
BALANCE
CARRIED TO THE B/S |
830.811 |
687.386 |
615.703 |
|
|
|
|
|
|
|
|
|
|
TOTAL EARNINGS
IN FOREIGN CURRENCY |
163.101 |
24.305 |
73.035 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
707.00 |
585.00 |
524.00 |
|
Expected Sales (2013-2014) : Rs.9000.000 Millions
The above information has been parted by Mr. Sanjay Agarwal (General
Manager Accounts and Finance)
KEY RATIOS
|
PARTICULARS |
|
31.03.2013 |
31.03.2012 |
31.03.2011 |
|
PAT / Total Income |
(%) |
10.39
|
10.67
|
10.68 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
13.34
|
13.87
|
13.82 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
15.63
|
15.26
|
15.62 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.25
|
0.28
|
0.28 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt /Networth) |
|
0.38
|
0.81
|
0.48 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.36
|
3.73
|
1.31 |
FINANCIAL ANALYSIS
[all figures are
in Rupees Millions]
DEBT EQUITY RATIO
|
Particular |
31.03.2012 |
31.03.2013 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Share Capital |
11.750 |
11.750 |
|
Reserves & Surplus |
3469.074 |
4299.884 |
|
Net
worth |
3,480.824 |
4,311.634 |
|
|
|
|
|
long-term borrowings |
115.943 |
68.600 |
|
Short term borrowings |
1196.363 |
436.092 |
|
Total
borrowings |
1,312.306 |
504.692 |
|
Debt/Equity
ratio |
0.377 |
0.117 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2011 |
31.03.2012 |
31.03.2013 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Sales |
5689.809 |
6496.314 |
7939.537 |
|
|
|
14.175 |
22.216 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2011 |
31.03.2012 |
31.03.2013 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Sales |
5689.809 |
6496.314 |
7939.537 |
|
Profit |
615.703 |
687.386 |
830.811 |
|
|
10.82% |
10.58% |
10.46% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
Yes |
|
9] |
Name of person contacted |
Yes |
|
10] |
Designation of contact
person |
Yes |
|
11] |
Turnover of firm for last
three years |
Yes |
|
12] |
Profitability for last
three years |
Yes |
|
13] |
Reasons for variation
<> 20% |
-- |
|
14] |
Estimation for coming
financial year |
Yes |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister
concerns |
Yes |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
Yes |
|
20] |
Export / Import details
(if applicable) |
Yes |
|
21] |
Market information |
-- |
|
22] |
Litigations that the firm
/ promoter involved in |
-- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking
account |
-- |
|
26] |
Buyer visit details |
-- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
Yes |
|
29] |
Last accounts filed at
ROC |
Yes |
|
30] |
Major Shareholders, if
available |
Yes |
|
31] |
Date of Birth of
Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of Proprietor/Partner/Director,
if available |
Yes |
|
33] |
Voter ID No of
Proprietor/Partner/Director, if available |
Yes |
|
34] |
External Agency Rating,
if available |
Yes |
FINANCIAL RESULTS
During the year, the Company had sales turnover of Rs. 7939.537 Millions Previous year Rs. 6496.314 Millions, an EBITDA of Rs. 1496.862 Millions (Previous year Rs1101.009 Millions) and made a net profit after tax of Rs. 831.601 Millions (Previous year Rs. 687.386 Millions)
PHARMA INDUSTRY
STRUCTURE AND DEVELOPMENTS:
India is now among the top five pharmaceutical emerging markets. The Indian pharma industry has been growing at a compounded annual growth rate (CAGR) of more than 15 per cent over the last five years and has significant growth opportunities. The Indian pharmaceutical sector is expected to grow five-fold to reach Rs 5 lakh crore (US$ 91.45 billion) by 2020, as per Dr A J V Prasad, Joint Secretary, Department of Pharmaceuticals (DoP). The industry, particularly, has been the front runner in a wide range of specialties involving complex drugs' manufacture, development, and technology. With the advantage of being a highly organized sector, the number of pharmaceutical companies are increasing their operations in India.
The pharmaceutical industry in India is an extremely fragmented market with severe price competition and government price control. The industry meets around 70 per cent of the country's demand for bulk drugs, drug intermediates, pharmaceutical formulations, chemicals, tablets, capsules, orals, and injectables. The pharmaceutical industry in India is highly regulated.
OUTLOOK:
Subject dedicates itself to humanity’s quest for longer, healthier, happier lives through innovation in pharmaceuticals formulations. Their mission is to remain demanding on the highest ethical standards, making their products and processes of the highest quality and; also being committed to meeting the needs of their customers, and constantly focus on customer satisfaction.
Akums has excellent future and they are expecting a growth rate much higher to the world’s pharma growth. Akums has eight plants, out which six are manufacturing plants and fully functional; other two are for R and D and Formulation development and Centralized Warehousing. Akums foresees to serve top pharmaceuticals companies of lobe and to have global manufacturing plants. Akums wants to lead the world of Manufacturing in virtually every area of Healthcare and wants to be of the top companies in Manufacturing of Pharmaceuticals.
INDEX
OF CHARGES
|
S.NO. |
CHARGE ID |
DATE OF CHARGE
CREATION/MODIFICATION |
CHARGE AMOUNT
SECURED |
CHARGE HOLDER |
ADDRESS |
SERVICE REQUEST
NUMBER (SRN) |
|
1 |
10217825 |
21/12/2010 * |
150,000,000.00 |
STANDARD CHARTERED BANK |
CREDIT RISK CONTROL,
NARAIN MANZIL, 23 BARAKHAMBA |
B01972181 |
|
2 |
10217291 |
21/12/2010 * |
250,000,000.00 |
STANDARD CHARTERED BANK (ACTING AS AN
SECURITY AGENT) |
CREDIT RISK
CONTROL, NARAIN MANZIL, 23 BARAKHAMBA |
B01972157 |
|
3 |
10019466 |
30/01/2012 * |
1,500,000,000.00 |
STATE BANK OF INDIA |
COMMERCIAL
BRANCH,, M-47, CONNAUGHT CIRCUS,, NEW |
B32485583 |
* Date of charge modification
FIXED ASSETS
Tangible assets
- Land
- Buildings
- Plant and equipment
- Furniture and fixtures
- Vehicles
- Office equipment
Intangible assets
- Brands and trade marks
- Licenses and franchise
- Licenses
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws, regulations
or policies that prohibit, restrict or otherwise affect the terms and
conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.60.49 |
|
|
1 |
Rs.99.77 |
|
Euro |
1 |
Rs.83.67 |
INFORMATION DETAILS
|
Information
Gathered by : |
PRT |
|
|
|
|
Report Prepared
by : |
KVT |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
7 |
|
PAID-UP CAPITAL |
1~10 |
6 |
|
OPERATING SCALE |
1~10 |
7 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
7 |
|
--PROFITABILIRY |
1~10 |
7 |
|
--LIQUIDITY |
1~10 |
6 |
|
--LEVERAGE |
1~10 |
7 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
7 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
60 |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.